Biocryst Pharmaceuticals (BCRX) Q1 2025 Earnings

24FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.21
-0.15
-0.1
-0.05

Details

Expected EPS
-0.046
Actual EPS
-0.13
Surprise EPS
-0.08
Surprise Percent
+182.61%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.13 per share for Q1 2025.

0 Comments

Share your thoughts